Jan 26, 2016
Qualidigm, announced today three new members to serve the organization’s Board of Directors, effective immediately:
M. Natalie Achong, MD, MHL is a Connecticut healthcare leader and researcher. She is the chairperson for health equity for the Connecticut State Medical Society where she develops and oversees health equity and population medicine programs and initiatives. She is an executive board member for the Hartford County Medical Association. Achong is a board certified obstetrician–gynecologist. Achong received her doctorate from New York University School of Medicine. She completed her residency training and is on faculty at Yale University School of Medicine. In May, Achong will graduate from Brown University with a master’s degree in healthcare leadership.
Michelle DeBarge is a partner in the Health Care Department at Wiggin and Dana LLP, a full service law firm with offices in Connecticut, New York, Philadelphia and Washington, DC. She chairs the HIPAA Practice Group, the Clinical Research Compliance Group, and also co-chairs the Cybersecurity and Privacy Group. With over twenty years of experience, DeBarge advises national and international businesses, health care organizations, and pharmaceutical/biotechnology companies on a wide-range of health care regulatory, operational, health information technology, privacy/security and clinical research issues. DeBarge has been recognized by Chambers USA in the category of health care lawyers, in The Best Lawyers in America and as a Connecticut “Super Lawyer.” She was also named by Best Lawyers as Hartford legal community’s “Health Care Law Lawyer of the Year” for 2012 and 2016. DeBarge graduated from Williams College and received her law degree from UCONN School of Law with high honors. She is an adjunct professor at the Quinnipiac University School of Law and former Chair of the Advisory Committee on Patient Privacy and Security to the State of Connecticut’s Health Information and Technology Exchange.
Alan S. Kliger, MD is a nephrologist, clinical professor of medicine at the Yale University School of Medicine, and senior vice president medical affairs, chief quality officer for the Yale New Haven Health System. Kliger formerly served as senior vice president, chief medical officer at Hospital of Saint Raphael, New Haven, Conn. He is a past president of the Renal Physicians Association, and serves on its Quality, Safety and Accountability Committee. Kliger also serves on the board of directors of the Kidney Health Initiative, a national partnership with the Food and Drug Administration, industry and professional organizations serving patients with kidney disease. He is chairman of the steering committee for the National Institutes for Health (NIH) Frequent Hemodialysis Study, a national prospective randomized study of in-center daily and home nocturnal hemodialysis, and also chairs the steering committee for an NIH/National Institute of Diabetes and Digestive and Kidney Diseases Consortium on Novel Therapies for Hemodialysis Patients.
“I am pleased to have three prominent and well-respected healthcare leaders who are passionate about our mission join our board,” said Timothy Elwell, Qualidigm president and CEO. “Natalie, Michelle and Alan bring a wealth of experience and knowledge to Qualidigm and will provide meaningful contributions to the future direction and growth of the company. I congratulate the newly elected board members and thank them for their commitment to Qualidigm.”
“Qualidigm is governed by a unique mix of seasoned and talented professionals whose energy and synergy contribute to Qualidigm’s strategic direction,” said Paul Liistro, chair of Qualidigm’s Board of Directors and managing partner of Hop Brook Limited Partnership in Manchester, Conn, a continuing care retirement community. “We are honored to add these accomplished, forward thinking visionaries with proven leadership skills to the Qualidigm Board of Directors to help further the organization’s mission.”